SCHEMBL7214808

SCHEMBL7214808

FC(F)(F)c1ccc(-c2ccccc2)[nH]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.43
ALDH1A1 P00352 3/20 0.43
HPGD P15428 3/20 0.43
CYP1A2 P05177 2/20 0.43
CYP2C9 P11712 2/20 0.43
SCN2A Q99250 4/20 0.42
NOTUM Q6P988 1/20 0.42
KIF11 P52732 1/20 0.41
GAA P10253 2/20 0.39
GLA P06280 2/20 0.39
HSD17B2 P37059 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.37
RAB9A P51151 3/20 0.36
NPC1 O15118 2/20 0.36
GFER P55789 1/20 0.36
POLB P06746 1/20 0.36
NPY5R Q15761 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9015133 0.79 KDM4E (0.46) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL19541221 0.78 NOTUM (0.42) KDM4EALDH1A1CYP1A2CYP2C9SCN2A
SCHEMBL1536003 0.75 NOTUM (0.56) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL18787989 0.73 NOTUM (0.54) KDM4EALDH1A1CYP1A2CYP2C9SCN2A
SCHEMBL18952025 0.70 NOTUM (0.46) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL28253288 0.68 ERCC1 (0.52) KDM4EALDH1A1HPGDNOTUMGAA
SCHEMBL17266947 0.67 NOTUM (0.54) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL25312090 0.65 KDM4E (0.48) KDM4EALDH1A1CYP1A2CYP2C9SCN2A
Piperazine SCHEMBL28833037 0.65 NOTUM (0.46) KDM4EALDH1A1HPGDCYP1A2CYP2C9
SCHEMBL1450720 0.65 HMBS (0.48) KDM4EALDH1A1HPGDCYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1369415-A1 Substituted pyrrolyl compounds for the treatment of inflammation G.D. SEARLE & CO. (US) 2003-12-10 EP disclosed
EP-0946507-B1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2003-09-24 EP disclosed
EP-0946507-A1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1999-10-06 EP disclosed
US-5935990-A PYRROLYL DERIVATIVES HAVING AT POSITION 1 OR 5 A PHENYL SUBSTITUTED WITH METHYLSULFONYL OR AMINOSULFONYL; INHIBIT CYCLOOXYGENASE-2 FOR USE TREATMENT OF INFLAMMATION, AS AN ANALGESIC, OR AS AN ANTIPYRETIC G.D. SEARLE & CO. (US) 1999-08-10 US disclosed
WO-1998025896-A1 SUBSTITUTED PYRROLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1998-06-18 WO disclosed
CN-1074439-A A kind of method from the synthetic trifluoromethyl pyrpole compounds of trifluoromethyl  oxazolone SHANGHAI INST ORGANIC CHEM (CN) 1993-07-21 CN disclosed